在生命与移植的钢丝绳上：危重症实体器官移植受者的免疫抑制 - Suppr

On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients.

作者信息

Azoulay Elie

机构信息

Intensive Care Department, APHP, Saint-Louis Hospital, Paris-Cité University, Paris, France.

INSERM UMR1342 Institut de Recherche Saint-Louis, Paris, France.

出版信息

Intensive Care Med. 2025 Sep;51(9):1699-1702. doi: 10.1007/s00134-025-08061-2. Epub 2025 Aug 19.

DOI:10.1007/s00134-025-08061-2

PMID:40828462

Abstract

摘要

相似文献

On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients.

Intensive Care Med. 2025 Sep;51(9):1699-1702. doi: 10.1007/s00134-025-08061-2. Epub 2025 Aug 19.

Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.

Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.

Novel association between graft rejection and post-transplant malignancy in solid organ transplantation.

World J Transplant. 2025 Jun 18;15(2):102384. doi: 10.5500/wjt.v15.i2.102384.

Synbiotics, prebiotics and probiotics for solid organ transplant recipients.

Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.

Recipient donor sex combinations in solid organ transplantation and impact on clinical outcome: A scoping review.

Clin Transplant. 2024 May;38(5):e15312. doi: 10.1111/ctr.15312.

Squamous and basal skin cancers in 17,207 solid organ transplant recipients: Real-world data from national health insurance database in Poland.

Adv Clin Exp Med. 2025 Jun;34(6):901-909. doi: 10.17219/acem/199653.

Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis.

Virol J. 2025 Jan 15;22(1):11. doi: 10.1186/s12985-025-02623-y.

COVID-19 and solid organ transplantation: Finding the right balance.

Transplant Rev (Orlando). 2022 Jul;36(3):100710. doi: 10.1016/j.trre.2022.100710. Epub 2022 Jul 4.

Elexacaftor-tezacaftor-ivacaftor use after solid organ transplant.

Curr Opin Pulm Med. 2024 Nov 1;30(6):660-666. doi: 10.1097/MCP.0000000000001110. Epub 2024 Jul 31.

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5.

本文引用的文献

Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically Ill patients with solid organ transplant: a retrospective multicenter study.

Intensive Care Med. 2025 Aug;51(8):1442-1452. doi: 10.1007/s00134-025-08024-7. Epub 2025 Jul 16.

Immunosuppression minimization and withdrawal in liver transplantation: The "holy grail"?

Transpl Immunol. 2025 Sep;92:102248. doi: 10.1016/j.trim.2025.102248. Epub 2025 Jun 2.

A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease.

Intensive Care Med. 2025 May;51(5):972-974. doi: 10.1007/s00134-025-07878-1. Epub 2025 May 23.

Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.

Intensive Care Med. 2024 Dec;50(12):2031-2042. doi: 10.1007/s00134-024-07665-4. Epub 2024 Oct 21.

Distinct immune profiles and clinical outcomes in sepsis subphenotypes based on temperature trajectories.

Intensive Care Med. 2024 Dec;50(12):2094-2104. doi: 10.1007/s00134-024-07669-0. Epub 2024 Oct 9.

Complement system activation: bridging physiology, pathophysiology, and therapy.

Intensive Care Med. 2024 Nov;50(11):1791-1803. doi: 10.1007/s00134-024-07611-4. Epub 2024 Sep 10.

Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia.

Intensive Care Med. 2024 Oct;50(10):1603-1613. doi: 10.1007/s00134-024-07613-2. Epub 2024 Sep 5.

Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients.

Gut. 2024 Sep 9;73(10):1650-1661. doi: 10.1136/gutjnl-2023-331441.

Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.

Transplantation. 2024 Nov 1;108(11):2278-2286. doi: 10.1097/TP.0000000000005065. Epub 2024 Oct 22.

Non-invasive molecular biomarkers for monitoring solid organ transplantation: A comprehensive overview.

Int J Immunogenet. 2024 Apr;51(2):47-62. doi: 10.1111/iji.12654. Epub 2024 Jan 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献